
As someone who has spent many years working across different regions and regulatory environments, I can say that the pharmacovigilance (PV) landscape in the Rest of the World (RoW) is quite complex and diverse. Unlike the US or Europe, where regulations are well-established and enforcement is consistent, many countries in the RoW are still developing…